| EIX |
Report |
Core / operating diluted EPS |
BEAT |
pred ~$1.28 vs. cons $1.265 |
MEDIUM |
| EIX |
Report |
SCE operating revenue |
IN-LINE |
pred ~$4.80B vs. cons $4.782B |
MEDIUM |
| EIX |
Report |
Average rate base |
IN-LINE |
pred ~$49.5B vs. cons $49.52B |
MEDIUM |
| EIX |
Guide |
FY26 Core EPS ($5.90-$6.20 range; FY26) |
UNCHANGED |
guide ~$6.05 midpoint vs. cons $6.125; range spans consensus |
MEDIUM |
| EIX |
Guide |
Long-term capital / no-equity / wildfire commentary (FY26-30) |
UNCHANGED |
reiterate ~7% rate-base CAGR, $38-41B plan, and no equity through 2030 |
MEDIUM |
| EIX |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
LOW |
| EIX |
Return |
5-day cumulative residual |
-2.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — maintained FY guide leaves out-period estimates exposed |
LOW |